: Acadia Pharmaceuticals stock halted for FDA panel to review treatment for hallucinations stemming from Alzheimer's disease psychosis #FinanceUSA #StockMarketNEWS Acadia Pharmaceuticals Inc. said
@stockMarketNEWS 15 Days ago
Acadia Pharmaceuticals stock halted for FDA panel to review treatment for hallucinations stemming from Alzheimer's disease psychosis #FinanceUSA #StockMarketNEWS
Acadia Pharmaceuticals Inc. said Friday its stock will be halted from trading Friday as a U.S. Food and Drug Administration panel meets virtually to discuss a new drug application for a treatment for hallucinations and delusions associated with Alzheimer's disease psychosis. The FDA's Psychopharmacologic Drugs Advisory Committee will review Acadia's Nuplazid at a meeting scheduled for 8:45 a.m. Eastern. About six million people living in the U.S. have Alzheimer's disease, according to the Alzheimer's Association and about 30% of those suffer from psychosis. Acadia shares have fallen 16% in the year to date, while the S&P 500 has fallen 23%.
Munafa USA Munafa India Munafa NSE
More posts by @stockMarketNEWS
: Canada delays rulemaking for cannabis beverages #FinanceUSA #StockMarketNEWS A Health Canada official told MJBiz that the agency does not expect to approve new regulations that would increase the possession
@stockMarketNEWS 15 Days ago
: WWE's Vince McMahon steps aside as CEO during investigation #FinanceUSA #StockMarketNEWS World Wrestling Entertainment Inc. Chief Executive Vince McMahon is stepping aside from that role as well
@stockMarketNEWS 15 Days ago
0 Comments
Sorted by latest first Latest Oldest Best
NSE Gainers NSE Losers BSE Gainers BSE Losers
Munafa NEWSTerms of Use Create Support ticket Your support tickets Powered by ePowerPress Stock Market News! Top Seo SMO © munafa.us2022 All Rights reserved.